PL449305A1 - Method for producing lupeol from betulin - Google Patents

Method for producing lupeol from betulin

Info

Publication number
PL449305A1
PL449305A1 PL449305A PL44930524A PL449305A1 PL 449305 A1 PL449305 A1 PL 449305A1 PL 449305 A PL449305 A PL 449305A PL 44930524 A PL44930524 A PL 44930524A PL 449305 A1 PL449305 A1 PL 449305A1
Authority
PL
Poland
Prior art keywords
betulin
lupeol
producing
numerous
application
Prior art date
Application number
PL449305A
Other languages
Polish (pl)
Other versions
PL249867B1 (en
Inventor
Dariusz Karcz
Arkadiusz Matwijczuk
Mariusz GAGOŚ
Marcin Domaciuk
Anna Jarosz-Wilkołazka
Ryszard Dobrowolski
Jacek Pietrusiewicz
Original Assignee
Uniwersytet Marii Curie-Skłodowskiej
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Marii Curie-Skłodowskiej filed Critical Uniwersytet Marii Curie-Skłodowskiej
Priority to PL449305A priority Critical patent/PL249867B1/en
Publication of PL449305A1 publication Critical patent/PL449305A1/en
Publication of PL249867B1 publication Critical patent/PL249867B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób otrzymywania lupeolu z betuliny, charakteryzującego się wieloma użytecznymi właściwościami biologicznymi, co powoduje, iż związek ten wraz ze swoimi pochodnymi znajduje zastosowanie jako składnik wielu kosmetyków pochodzenia naturalnego, a także leków o działaniu przeciwalergicznym, przeciwzapalnym oraz przeciwwirusowym. Zgłoszenie rozwiązuje problem techniczny w postaci opracowania nowego sposobu otrzymywania lupeolu z betuliny o wysokiej klasie czystości, z produktami pośrednimi nie wymagającymi izolacji.The subject of the application is a method for obtaining lupeol from betulin, which is characterized by numerous useful biological properties, making this compound and its derivatives useful as a component of numerous natural cosmetics, as well as drugs with antiallergic, anti-inflammatory, and antiviral properties. The application addresses a technical problem by developing a new method for obtaining lupeol from betulin of high purity, with intermediate products requiring no isolation.

PL449305A 2024-07-23 2024-07-23 Method of obtaining lupeol from betulin PL249867B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL449305A PL249867B1 (en) 2024-07-23 2024-07-23 Method of obtaining lupeol from betulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449305A PL249867B1 (en) 2024-07-23 2024-07-23 Method of obtaining lupeol from betulin

Publications (2)

Publication Number Publication Date
PL449305A1 true PL449305A1 (en) 2026-01-26
PL249867B1 PL249867B1 (en) 2026-07-06

Family

ID=98521454

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449305A PL249867B1 (en) 2024-07-23 2024-07-23 Method of obtaining lupeol from betulin

Country Status (1)

Country Link
PL (1) PL249867B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL390788A1 (en) * 2010-03-22 2011-09-26 Uniwersytet Marii Curie-Skłodowskiej Betulin used as a drug for liver disease
PL418919A1 (en) * 2016-09-29 2018-04-09 Politechnika Krakowska im. Tadeusza Kościuszki Method for producing new derivative of lupeol
PL442167A1 (en) * 2022-09-01 2024-03-04 Uniwersytet Medyczny W Lublinie Method of obtaining an extract containing betulin from silver birch bark

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL390788A1 (en) * 2010-03-22 2011-09-26 Uniwersytet Marii Curie-Skłodowskiej Betulin used as a drug for liver disease
PL418919A1 (en) * 2016-09-29 2018-04-09 Politechnika Krakowska im. Tadeusza Kościuszki Method for producing new derivative of lupeol
PL442167A1 (en) * 2022-09-01 2024-03-04 Uniwersytet Medyczny W Lublinie Method of obtaining an extract containing betulin from silver birch bark

Also Published As

Publication number Publication date
PL249867B1 (en) 2026-07-06

Similar Documents

Publication Publication Date Title
Kaminskyy et al. Synthesis of new potential anticancer agents based on 4-thiazolidinone and oleanane scaffolds
CY1118475T1 (en) ANTI-OXYGEN INFLAMMATORY REGULATORS: C-17 OLANOLIC ACID PRODUCERS
JO2793B1 (en) The new crystalline form 5 of agomelatine, its preparation process and the pharmaceutical ingredients it contains
BR112023000763A2 (en) PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING 177LU-PSMA I&T, METHOD FOR TREATMENT OF A PATIENT, COMPLEX, METHOD FOR TREATMENT OF AN INDIVIDUAL
NZ523957A (en) 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent
BR122019010008B8 (en) pyrimidine derivatives, their use, and pharmaceutical composition and combination
UY30712A1 (en) NEW DERIVATIVES OF 1, 4-BENZOTIEPINA-1, 1-DIOXIDE REPLACED WITH FLUOR, METHOD FOR PREPARATION, PHARMACEUTICAL PRODUCTS THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE.
ES2170734A1 (en) METHOD FOR THE PREPARATION OF CITALOPRAM.
Arantes et al. Synthesis and cytotoxic activity of α-santonin derivatives
UY28253A1 (en) NEW DIFENILAZETIDINONA WITH IMPROVED PHYSIOLOGICAL PROPERTIES, PROCEDURE FOR THEIR PREPARATION, DRUGS THAT UNDERSTAND THIS COMPOSITE AND ITS USE.
MX2022002603A (en) INDUSTRIAL PROCESS FOR THE PREPARATION OF HIGH PURITY ESTETROL.
EA200601271A1 (en) NEW CRYSTAL FORM IV OF AGOMELATIN, THE METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS
Mallavadhani et al. Synthesis and anti-cancer activity of some novel C-17 analogs of ursolic and oleanolic acids
Yang et al. New labdane diterpenoids from Croton laui and their anti-inflammatory activities
EA200601274A1 (en) NEW CRYSTAL FORM III OF AGOMELATIN, THE METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS
Djerassi et al. Steroidal Sapogenins. Xv. Experiments in the Hecogenin Series (part 3). 1 Conversion to Cortisone
DE60201890D1 (en) SYNTHESIS OF BETA-LAPACHONE AND RELATED INTERIM PRODUCTS
BR112023005443A2 (en) HETEROCYCLIC SUBSTITUTED fused Y-CARBOLINE DERIVATIVE, METHOD OF PREPARATION OF THE SAME, INTERMEDIATE OF THE SAME AND USE OF THE SAME
ATE382355T1 (en) COMPOSITION CONTAINING AN ANDROGENIC 11-B HALOGEN STEROID AND A GEGESGEN AND MALE CONTRACEPTIVE BASED ON THIS COMPOSITION
Szaloki et al. Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity
Sun et al. Mufolinin A, an unprecedented ring A-seco 10-ethyllimonoid from Munronia unifoliolata
Lee et al. Antiinflammatory activity of isoflavonoids from Pueraria radix and biochanin A derivatives
Wang et al. Syntheses and bioactivities of songorine derivatives as novel G protein-coupled receptor antagonists
Misra et al. Constituents of Asteracantha longifolia
Cimino et al. Naturally occurring prostaglandin-1, 15-lactones